Clinical Trials Browser

Esophageal Squamous Cell Carcinoma, Carcinoma, Basal Cell, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06235203 2025-06-03

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

Phase 3 Recruiting

154 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT07000643 2025-06-03

Phase III Non-Inferiority Trial of Proton Versus Photon Therapy for Nasopharyngeal Carcinoma

Phase 3 Recruiting

386 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04178174 2025-05-18

SHORT-OPC

Phase 3 Recruiting

360 enrolled

Head & Neck

Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT06064877 2025-04-13

FIERCE-HN

Phase 3 Recruiting

410 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Neoplasm Metastasis, Recurrence

NCT06752239 2025-04-10

PROTECT-NPC

Phase 3 Recruiting

474 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Radiation Injuries, Thyroid Diseases

NCT06712888 2025-03-18

Navigation

Phase 3 Recruiting

466 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06258811 2025-03-13

Neoadjuvant Immunochemotherapy for LAOSCC

Phase 3 Recruiting

134 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT06737822 2025-03-04

SurVIC

Phase 3 Recruiting

346 enrolled

Head & Neck

Head and Neck Neoplasms, Mouth Neoplasms

NCT06629597 2025-02-10

A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma

Phase 3 Recruiting

400 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03907826 2025-01-28

PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients

Phase 3 Recruiting

212 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05780372 2025-01-28

Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

Phase 3 Recruiting

474 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06791005 2025-01-24

A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.

Phase 3 Recruiting

400 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT06675214 2024-11-05

Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.

Phase 3 Recruiting

586 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04747054 2024-10-26

PembroMetaRT

Phase 3 Recruiting

102 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, Neoplasm Metastasis

Clinical Trials

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

HOPE

Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma

OPTIFLAP

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

RePaIr-HN

Selective Neck Dissection Versus Modified Neck Dissection in PTC

Adjuvant Radiotherapy in High Risk Locally Advanced DTC

A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

PROLoNg

Magic-C002

Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial

SELECT

Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma

A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma

INCIPT-NPC

Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer

Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.

Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer

ECLIPSE

INTERMEDIATE

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

JADE

Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy

Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible

2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma

MOIO

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

Phase III Non-Inferiority Trial of Proton Versus Photon Therapy for Nasopharyngeal Carcinoma

SHORT-OPC

FIERCE-HN

PROTECT-NPC

Navigation

Neoadjuvant Immunochemotherapy for LAOSCC

SurVIC

A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma

PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients

Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.

Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.

PembroMetaRT